Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
CNY 13.93
(-0.5%)
CNY 13.93
(-0.5%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.55 Billion CNY | -9.14% |
| 2022 | 6.1 Billion CNY | 13.33% |
| 2021 | 5.39 Billion CNY | 18.92% |
| 2020 | 4.53 Billion CNY | 11.8% |
| 2019 | 4.05 Billion CNY | 9.03% |
| 2018 | 3.71 Billion CNY | 15.55% |
| 2017 | 3.21 Billion CNY | 24.76% |
| 2016 | 2.57 Billion CNY | 15.65% |
| 2015 | 2.23 Billion CNY | 24.58% |
| 2014 | 1.79 Billion CNY | 27.52% |
| 2013 | 1.4 Billion CNY | 29.52% |
| 2012 | 1.08 Billion CNY | 25.69% |
| 2011 | 862.59 Million CNY | 24.97% |
| 2010 | 690.24 Million CNY | 29.99% |
| 2009 | 531 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 1.36 Billion CNY | 3.56% |
| 2024 Q1 | 1.53 Billion CNY | 8.48% |
| 2024 Q2 | 1.33 Billion CNY | -12.94% |
| 2023 Q4 | 1.41 Billion CNY | 6.36% |
| 2023 Q1 | 1.48 Billion CNY | -20.53% |
| 2023 Q2 | 1.42 Billion CNY | -4.2% |
| 2023 FY | 5.55 Billion CNY | -9.14% |
| 2023 Q3 | 1.33 Billion CNY | -6.45% |
| 2022 Q1 | 1.34 Billion CNY | -2.83% |
| 2022 FY | 6.1 Billion CNY | 13.33% |
| 2022 Q4 | 1.87 Billion CNY | 26.74% |
| 2022 Q3 | 1.47 Billion CNY | 4.51% |
| 2022 Q2 | 1.41 Billion CNY | 4.72% |
| 2021 FY | 5.39 Billion CNY | 18.92% |
| 2021 Q4 | 1.38 Billion CNY | -0.71% |
| 2021 Q3 | 1.39 Billion CNY | 4.69% |
| 2021 Q2 | 1.33 Billion CNY | 5.25% |
| 2021 Q1 | 1.26 Billion CNY | 7.0% |
| 2020 Q3 | 1.16 Billion CNY | 9.24% |
| 2020 FY | 4.53 Billion CNY | 11.8% |
| 2020 Q1 | 1.11 Billion CNY | 3.09% |
| 2020 Q2 | 1.06 Billion CNY | -4.56% |
| 2020 Q4 | 1.18 Billion CNY | 1.84% |
| 2019 Q4 | 1.08 Billion CNY | 7.41% |
| 2019 FY | 4.05 Billion CNY | 9.03% |
| 2019 Q3 | 1 Billion CNY | 3.32% |
| 2019 Q2 | 976.36 Million CNY | -1.01% |
| 2019 Q1 | 986.33 Million CNY | -2.7% |
| 2018 Q2 | 905.51 Million CNY | 1.82% |
| 2018 Q1 | 889.35 Million CNY | -3.85% |
| 2018 FY | 3.71 Billion CNY | 15.55% |
| 2018 Q4 | 1.01 Billion CNY | 11.32% |
| 2018 Q3 | 910.63 Million CNY | 0.57% |
| 2017 Q2 | 774.48 Million CNY | 7.35% |
| 2017 Q1 | 721.48 Million CNY | 4.59% |
| 2017 FY | 3.21 Billion CNY | 24.76% |
| 2017 Q4 | 924.95 Million CNY | 15.96% |
| 2017 Q3 | 797.68 Million CNY | 3.0% |
| 2016 Q1 | 631.14 Million CNY | 2.16% |
| 2016 Q2 | 620.84 Million CNY | -1.63% |
| 2016 FY | 2.57 Billion CNY | 15.65% |
| 2016 Q3 | 638.12 Million CNY | 2.78% |
| 2016 Q4 | 689.81 Million CNY | 8.1% |
| 2015 Q4 | 617.82 Million CNY | 7.79% |
| 2015 FY | 2.23 Billion CNY | 24.58% |
| 2015 Q2 | 543.33 Million CNY | 9.43% |
| 2015 Q1 | 496.49 Million CNY | 3.96% |
| 2015 Q3 | 573.19 Million CNY | 5.5% |
| 2014 Q2 | 452.25 Million CNY | 7.7% |
| 2014 FY | 1.79 Billion CNY | 27.52% |
| 2014 Q4 | 477.56 Million CNY | 8.31% |
| 2014 Q3 | 440.93 Million CNY | -2.5% |
| 2014 Q1 | 419.9 Million CNY | 5.54% |
| 2013 Q4 | 397.84 Million CNY | 13.82% |
| 2013 FY | 1.4 Billion CNY | 29.52% |
| 2013 Q2 | 330.63 Million CNY | 1.36% |
| 2013 Q3 | 349.52 Million CNY | 5.71% |
| 2013 Q1 | 326.2 Million CNY | 0.0% |
| 2012 FY | 1.08 Billion CNY | 25.69% |
| 2011 FY | 862.59 Million CNY | 24.97% |
| 2010 FY | 690.24 Million CNY | 29.99% |
| 2009 FY | 531 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 1.97 Billion CNY | -180.679% |
| ZJAMP Group Co., Ltd. | 2.51 Billion CNY | -120.435% |
| Luyan Pharma Co.,Ltd. | 1.5 Billion CNY | -268.476% |
| Ji Yao Holding Group Co., Ltd. | 81.67 Million CNY | -6696.116% |